Reilly Dennis Insider Trades

Insider Trading History

Track insider trading activity for Reilly Dennis. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $415k 275,000 shares
Last Trade
Jan 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.41B 275,000 shares
$34,200.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $431k 285,130 shares
Last Trade
Oct 13, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.98B 88,236 shares
$79,070.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $342k 226,306 shares
Last Trade
Jul 27, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.55B 50,000 shares
$111,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $266k 176,306 shares
Last Trade
May 11, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.66B 20,000 shares
$133,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $236k 156,306 shares
Last Trade
Mar 23, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.4B 50,000 shares
$188,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $458k 303,030 shares
Last Trade
Jan 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.5B 303,030 shares
$282,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $161k 106,306 shares
Last Trade
Sep 28, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.56B 9,000 shares
$284,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $170k 112,500 shares
Last Trade
Aug 26, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.6B 37,500 shares
$308,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $147k 97,306 shares
Last Trade
Aug 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.6B 37,500 shares
$308,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $90.3k 59,806 shares
Last Trade
Mar 04, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.6B 75,000 shares
$234,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $466k 308,333 shares
Last Trade
Jan 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90B 318,139 shares
$283,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $227k 150,000 shares
Last Trade
Aug 05, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.2B 150,000 shares
$101,000.00
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up